Transforming TGF-β suppression into IL-15 stimulation: Advancing engineered CAR-T therapy for solid tumors.

Mol Ther

Laboratory of Cell & Gene Therapy, Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea. Electronic address:

Published: January 2025

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2025.01.002DOI Listing

Publication Analysis

Top Keywords

transforming tgf-β
4
tgf-β suppression
4
suppression il-15
4
il-15 stimulation
4
stimulation advancing
4
advancing engineered
4
engineered car-t
4
car-t therapy
4
therapy solid
4
solid tumors
4

Similar Publications

The inflammatory response of lung tissue and abnormal proliferation of pulmonary artery smooth muscle cells are involved in the pathogenesis of high-altitude pulmonary hypertension (HAPH). Halofuginone (HF), an active ingredient derivative of Chang Shan (Dichroa febrifuga Lour. [Hydrangeaceae]), has antiproliferative, antihypertrophic, antifibrotic, and other effects, but its protective effects on HAPH remains unclear.

View Article and Find Full Text PDF

Air pollution in cities, especially NO, is linked to numerous health problems, ranging from mortality to mental health challenges and attention deficits in children. While cities globally have initiated policies to curtail emissions, real-time monitoring remains challenging due to limited environmental sensors and their inconsistent distribution. This gap hinders the creation of adaptive urban policies that respond to the sequence of events and daily activities affecting pollution in cities.

View Article and Find Full Text PDF

Palmatine (PAL) and berberine are both classified as protoberberine alkaloids, derived from several traditional Chinese herbs such as Franch. and   Schneid. These compounds are extensively used in treating dysentery and colitis.

View Article and Find Full Text PDF

Transforming Transplantation Access: A Federal Directive for Comprehensive Pre-Waitlisting Data Collection.

Am J Transplant

January 2025

Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.

There is substantial variation in access to transplantation across the United States that is not entirely explained by the availability of donor organs. Barriers to transplantation and variation in care among patients with end-stage organ disease exist prior to patients' placement on a transplant waiting list as well as following waitlist placement. However, there are currently no national data available to examine rates and variations in key care processes related to pre-listing, including transplant referral, evaluation, or candidate selection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!